ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Mycoplasma Hyopneumoniae Vaccine Market Research Report 2025
Published Date: July 2025
|
Report Code: QYRE-Auto-37S6000
Home | Market Reports | Health| Health Conditions| Infectious Diseases
Global Mycoplasma Hyopneumoniae Vaccine Market Insights Forecast to 2028
BUY CHAPTERS

Global Mycoplasma Hyopneumoniae Vaccine Market Research Report 2025

Code: QYRE-Auto-37S6000
Report
July 2025
Pages:88
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Zoetis Inc
Merck
Ceva Santé Animale
Elanco Animal Health
Qilu Animal Health
Ruipu
Shanghai Hile Bio-Technology Co., Ltd.
CAHIC
Pulike
Harbin Pharmaceutical Group
Boehringer Ingelheim

Mycoplasma Hyopneumoniae Vaccine Market

The global market for Mycoplasma Hyopneumoniae Vaccine was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Mycoplasma Hyopneumoniae Vaccine can effectively prevent Mycoplasma suis. Mycoplasma pneumonia has always been regarded as one of the most widespread diseases that cause major economic losses to the pig industry.
North American market for Mycoplasma Hyopneumoniae Vaccine is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Mycoplasma Hyopneumoniae Vaccine is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global manufacturers of Mycoplasma Hyopneumoniae Vaccine include Zoetis, Merck, Boehringer Ingelheim, Ceva Santé Animale, Elanco Animal Health, Qilu Animal Health, Ruipu, Shanghai Hile Bio-Technology Co., Ltd., CAHIC, Pulike, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Mycoplasma Hyopneumoniae Vaccine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Mycoplasma Hyopneumoniae Vaccine.
The Mycoplasma Hyopneumoniae Vaccine market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Mycoplasma Hyopneumoniae Vaccine market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Mycoplasma Hyopneumoniae Vaccine manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Mycoplasma Hyopneumoniae Vaccine Market Report

Report Metric Details
Report Name Mycoplasma Hyopneumoniae Vaccine Market
Segment by Type
  • Live
  • Inactivated
Segment by Application
  • Piglets
  • Adult Pigs
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Zoetis, Merck, Boehringer Ingelheim, Ceva Santé Animale, Elanco Animal Health, Qilu Animal Health, Ruipu, Shanghai Hile Bio-Technology Co., Ltd., CAHIC, Pulike, Harbin Pharmaceutical Group
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Mycoplasma Hyopneumoniae Vaccine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Mycoplasma Hyopneumoniae Vaccine in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

Who are the main players in the Mycoplasma Hyopneumoniae Vaccine Market report?

Ans: The main players in the Mycoplasma Hyopneumoniae Vaccine Market are Zoetis, Merck, Boehringer Ingelheim, Ceva Santé Animale, Elanco Animal Health, Qilu Animal Health, Ruipu, Shanghai Hile Bio-Technology Co., Ltd., CAHIC, Pulike, Harbin Pharmaceutical Group

What are the Application segmentation covered in the Mycoplasma Hyopneumoniae Vaccine Market report?

Ans: The Applications covered in the Mycoplasma Hyopneumoniae Vaccine Market report are Piglets, Adult Pigs

What are the Type segmentation covered in the Mycoplasma Hyopneumoniae Vaccine Market report?

Ans: The Types covered in the Mycoplasma Hyopneumoniae Vaccine Market report are Live, Inactivated

1 Mycoplasma Hyopneumoniae Vaccine Market Overview
1.1 Product Definition
1.2 Mycoplasma Hyopneumoniae Vaccine by Type
1.2.1 Global Mycoplasma Hyopneumoniae Vaccine Market Value Comparison by Type (2024 VS 2031)
1.2.2 Live
1.2.3 Inactivated
1.3 Mycoplasma Hyopneumoniae Vaccine by Application
1.3.1 Global Mycoplasma Hyopneumoniae Vaccine Market Value by Application (2024 VS 2031)
1.3.2 Piglets
1.3.3 Adult Pigs
1.4 Global Mycoplasma Hyopneumoniae Vaccine Market Size Estimates and Forecasts
1.4.1 Global Mycoplasma Hyopneumoniae Vaccine Revenue 2020-2031
1.4.2 Global Mycoplasma Hyopneumoniae Vaccine Sales 2020-2031
1.4.3 Global Mycoplasma Hyopneumoniae Vaccine Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Mycoplasma Hyopneumoniae Vaccine Market Competition by Manufacturers
2.1 Global Mycoplasma Hyopneumoniae Vaccine Sales Market Share by Manufacturers (2020-2025)
2.2 Global Mycoplasma Hyopneumoniae Vaccine Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Mycoplasma Hyopneumoniae Vaccine Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Mycoplasma Hyopneumoniae Vaccine, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Mycoplasma Hyopneumoniae Vaccine, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Mycoplasma Hyopneumoniae Vaccine, Product Type & Application
2.7 Global Key Manufacturers of Mycoplasma Hyopneumoniae Vaccine, Date of Enter into This Industry
2.8 Global Mycoplasma Hyopneumoniae Vaccine Market Competitive Situation and Trends
2.8.1 Global Mycoplasma Hyopneumoniae Vaccine Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Mycoplasma Hyopneumoniae Vaccine Players Market Share by Revenue
2.8.3 Global Mycoplasma Hyopneumoniae Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Mycoplasma Hyopneumoniae Vaccine Market Scenario by Region
3.1 Global Mycoplasma Hyopneumoniae Vaccine Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Mycoplasma Hyopneumoniae Vaccine Sales by Region: 2020-2031
3.2.1 Global Mycoplasma Hyopneumoniae Vaccine Sales by Region: 2020-2025
3.2.2 Global Mycoplasma Hyopneumoniae Vaccine Sales by Region: 2026-2031
3.3 Global Mycoplasma Hyopneumoniae Vaccine Revenue by Region: 2020-2031
3.3.1 Global Mycoplasma Hyopneumoniae Vaccine Revenue by Region: 2020-2025
3.3.2 Global Mycoplasma Hyopneumoniae Vaccine Revenue by Region: 2026-2031
3.4 North America Mycoplasma Hyopneumoniae Vaccine Market Facts & Figures by Country
3.4.1 North America Mycoplasma Hyopneumoniae Vaccine Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Mycoplasma Hyopneumoniae Vaccine Sales by Country (2020-2031)
3.4.3 North America Mycoplasma Hyopneumoniae Vaccine Revenue by Country (2020-2031)
3.4.4 United States
3.4.5 Canada
3.5 Europe Mycoplasma Hyopneumoniae Vaccine Market Facts & Figures by Country
3.5.1 Europe Mycoplasma Hyopneumoniae Vaccine Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Mycoplasma Hyopneumoniae Vaccine Sales by Country (2020-2031)
3.5.3 Europe Mycoplasma Hyopneumoniae Vaccine Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Mycoplasma Hyopneumoniae Vaccine Market Facts & Figures by Region
3.6.1 Asia Pacific Mycoplasma Hyopneumoniae Vaccine Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Mycoplasma Hyopneumoniae Vaccine Sales by Region (2020-2031)
3.6.3 Asia Pacific Mycoplasma Hyopneumoniae Vaccine Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Mycoplasma Hyopneumoniae Vaccine Market Facts & Figures by Country
3.7.1 Latin America Mycoplasma Hyopneumoniae Vaccine Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Mycoplasma Hyopneumoniae Vaccine Sales by Country (2020-2031)
3.7.3 Latin America Mycoplasma Hyopneumoniae Vaccine Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Mycoplasma Hyopneumoniae Vaccine Market Facts & Figures by Country
3.8.1 Middle East and Africa Mycoplasma Hyopneumoniae Vaccine Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Mycoplasma Hyopneumoniae Vaccine Sales by Country (2020-2031)
3.8.3 Middle East and Africa Mycoplasma Hyopneumoniae Vaccine Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Mycoplasma Hyopneumoniae Vaccine Sales by Type (2020-2031)
4.1.1 Global Mycoplasma Hyopneumoniae Vaccine Sales by Type (2020-2025)
4.1.2 Global Mycoplasma Hyopneumoniae Vaccine Sales by Type (2026-2031)
4.1.3 Global Mycoplasma Hyopneumoniae Vaccine Sales Market Share by Type (2020-2031)
4.2 Global Mycoplasma Hyopneumoniae Vaccine Revenue by Type (2020-2031)
4.2.1 Global Mycoplasma Hyopneumoniae Vaccine Revenue by Type (2020-2025)
4.2.2 Global Mycoplasma Hyopneumoniae Vaccine Revenue by Type (2026-2031)
4.2.3 Global Mycoplasma Hyopneumoniae Vaccine Revenue Market Share by Type (2020-2031)
4.3 Global Mycoplasma Hyopneumoniae Vaccine Price by Type (2020-2031)
5 Segment by Application
5.1 Global Mycoplasma Hyopneumoniae Vaccine Sales by Application (2020-2031)
5.1.1 Global Mycoplasma Hyopneumoniae Vaccine Sales by Application (2020-2025)
5.1.2 Global Mycoplasma Hyopneumoniae Vaccine Sales by Application (2026-2031)
5.1.3 Global Mycoplasma Hyopneumoniae Vaccine Sales Market Share by Application (2020-2031)
5.2 Global Mycoplasma Hyopneumoniae Vaccine Revenue by Application (2020-2031)
5.2.1 Global Mycoplasma Hyopneumoniae Vaccine Revenue by Application (2020-2025)
5.2.2 Global Mycoplasma Hyopneumoniae Vaccine Revenue by Application (2026-2031)
5.2.3 Global Mycoplasma Hyopneumoniae Vaccine Revenue Market Share by Application (2020-2031)
5.3 Global Mycoplasma Hyopneumoniae Vaccine Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Zoetis
6.1.1 Zoetis Company Information
6.1.2 Zoetis Description and Business Overview
6.1.3 Zoetis Mycoplasma Hyopneumoniae Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Zoetis Mycoplasma Hyopneumoniae Vaccine Product Portfolio
6.1.5 Zoetis Recent Developments/Updates
6.2 Merck
6.2.1 Merck Company Information
6.2.2 Merck Description and Business Overview
6.2.3 Merck Mycoplasma Hyopneumoniae Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Merck Mycoplasma Hyopneumoniae Vaccine Product Portfolio
6.2.5 Merck Recent Developments/Updates
6.3 Boehringer Ingelheim
6.3.1 Boehringer Ingelheim Company Information
6.3.2 Boehringer Ingelheim Description and Business Overview
6.3.3 Boehringer Ingelheim Mycoplasma Hyopneumoniae Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Boehringer Ingelheim Mycoplasma Hyopneumoniae Vaccine Product Portfolio
6.3.5 Boehringer Ingelheim Recent Developments/Updates
6.4 Ceva Santé Animale
6.4.1 Ceva Santé Animale Company Information
6.4.2 Ceva Santé Animale Description and Business Overview
6.4.3 Ceva Santé Animale Mycoplasma Hyopneumoniae Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Ceva Santé Animale Mycoplasma Hyopneumoniae Vaccine Product Portfolio
6.4.5 Ceva Santé Animale Recent Developments/Updates
6.5 Elanco Animal Health
6.5.1 Elanco Animal Health Company Information
6.5.2 Elanco Animal Health Description and Business Overview
6.5.3 Elanco Animal Health Mycoplasma Hyopneumoniae Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Elanco Animal Health Mycoplasma Hyopneumoniae Vaccine Product Portfolio
6.5.5 Elanco Animal Health Recent Developments/Updates
6.6 Qilu Animal Health
6.6.1 Qilu Animal Health Company Information
6.6.2 Qilu Animal Health Description and Business Overview
6.6.3 Qilu Animal Health Mycoplasma Hyopneumoniae Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Qilu Animal Health Mycoplasma Hyopneumoniae Vaccine Product Portfolio
6.6.5 Qilu Animal Health Recent Developments/Updates
6.7 Ruipu
6.7.1 Ruipu Company Information
6.7.2 Ruipu Description and Business Overview
6.7.3 Ruipu Mycoplasma Hyopneumoniae Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Ruipu Mycoplasma Hyopneumoniae Vaccine Product Portfolio
6.7.5 Ruipu Recent Developments/Updates
6.8 Shanghai Hile Bio-Technology Co., Ltd.
6.8.1 Shanghai Hile Bio-Technology Co., Ltd. Company Information
6.8.2 Shanghai Hile Bio-Technology Co., Ltd. Description and Business Overview
6.8.3 Shanghai Hile Bio-Technology Co., Ltd. Mycoplasma Hyopneumoniae Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Shanghai Hile Bio-Technology Co., Ltd. Mycoplasma Hyopneumoniae Vaccine Product Portfolio
6.8.5 Shanghai Hile Bio-Technology Co., Ltd. Recent Developments/Updates
6.9 CAHIC
6.9.1 CAHIC Company Information
6.9.2 CAHIC Description and Business Overview
6.9.3 CAHIC Mycoplasma Hyopneumoniae Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.9.4 CAHIC Mycoplasma Hyopneumoniae Vaccine Product Portfolio
6.9.5 CAHIC Recent Developments/Updates
6.10 Pulike
6.10.1 Pulike Company Information
6.10.2 Pulike Description and Business Overview
6.10.3 Pulike Mycoplasma Hyopneumoniae Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.10.4 Pulike Mycoplasma Hyopneumoniae Vaccine Product Portfolio
6.10.5 Pulike Recent Developments/Updates
6.11 Harbin Pharmaceutical Group
6.11.1 Harbin Pharmaceutical Group Company Information
6.11.2 Harbin Pharmaceutical Group Description and Business Overview
6.11.3 Harbin Pharmaceutical Group Mycoplasma Hyopneumoniae Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.11.4 Harbin Pharmaceutical Group Mycoplasma Hyopneumoniae Vaccine Product Portfolio
6.11.5 Harbin Pharmaceutical Group Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Mycoplasma Hyopneumoniae Vaccine Industry Chain Analysis
7.2 Mycoplasma Hyopneumoniae Vaccine Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Mycoplasma Hyopneumoniae Vaccine Production Mode & Process Analysis
7.4 Mycoplasma Hyopneumoniae Vaccine Sales and Marketing
7.4.1 Mycoplasma Hyopneumoniae Vaccine Sales Channels
7.4.2 Mycoplasma Hyopneumoniae Vaccine Distributors
7.5 Mycoplasma Hyopneumoniae Vaccine Customer Analysis
8 Mycoplasma Hyopneumoniae Vaccine Market Dynamics
8.1 Mycoplasma Hyopneumoniae Vaccine Industry Trends
8.2 Mycoplasma Hyopneumoniae Vaccine Market Drivers
8.3 Mycoplasma Hyopneumoniae Vaccine Market Challenges
8.4 Mycoplasma Hyopneumoniae Vaccine Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
FEATURED COMPANIES
Zoetis Inc
Merck
Ceva Santé Animale
Elanco Animal Health
Qilu Animal Health
Ruipu
Shanghai Hile Bio-Technology Co., Ltd.
CAHIC
Pulike
Harbin Pharmaceutical Group
Boehringer Ingelheim
List of Tables
 Table 1. Global Mycoplasma Hyopneumoniae Vaccine Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global Mycoplasma Hyopneumoniae Vaccine Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global Mycoplasma Hyopneumoniae Vaccine Market Competitive Situation by Manufacturers in 2024
 Table 4. Global Mycoplasma Hyopneumoniae Vaccine Sales (K Units) of Key Manufacturers (2020-2025)
 Table 5. Global Mycoplasma Hyopneumoniae Vaccine Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global Mycoplasma Hyopneumoniae Vaccine Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global Mycoplasma Hyopneumoniae Vaccine Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market Mycoplasma Hyopneumoniae Vaccine Average Price (US$/Unit) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of Mycoplasma Hyopneumoniae Vaccine, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Mycoplasma Hyopneumoniae Vaccine, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Mycoplasma Hyopneumoniae Vaccine, Product Type & Application
 Table 12. Global Key Manufacturers of Mycoplasma Hyopneumoniae Vaccine, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Mycoplasma Hyopneumoniae Vaccine by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Mycoplasma Hyopneumoniae Vaccine as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Mycoplasma Hyopneumoniae Vaccine Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global Mycoplasma Hyopneumoniae Vaccine Sales by Region (2020-2025) & (K Units)
 Table 18. Global Mycoplasma Hyopneumoniae Vaccine Sales Market Share by Region (2020-2025)
 Table 19. Global Mycoplasma Hyopneumoniae Vaccine Sales by Region (2026-2031) & (K Units)
 Table 20. Global Mycoplasma Hyopneumoniae Vaccine Sales Market Share by Region (2026-2031)
 Table 21. Global Mycoplasma Hyopneumoniae Vaccine Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global Mycoplasma Hyopneumoniae Vaccine Revenue Market Share by Region (2020-2025)
 Table 23. Global Mycoplasma Hyopneumoniae Vaccine Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global Mycoplasma Hyopneumoniae Vaccine Revenue Market Share by Region (2026-2031)
 Table 25. North America Mycoplasma Hyopneumoniae Vaccine Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America Mycoplasma Hyopneumoniae Vaccine Sales by Country (2020-2025) & (K Units)
 Table 27. North America Mycoplasma Hyopneumoniae Vaccine Sales by Country (2026-2031) & (K Units)
 Table 28. North America Mycoplasma Hyopneumoniae Vaccine Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America Mycoplasma Hyopneumoniae Vaccine Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe Mycoplasma Hyopneumoniae Vaccine Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe Mycoplasma Hyopneumoniae Vaccine Sales by Country (2020-2025) & (K Units)
 Table 32. Europe Mycoplasma Hyopneumoniae Vaccine Sales by Country (2026-2031) & (K Units)
 Table 33. Europe Mycoplasma Hyopneumoniae Vaccine Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe Mycoplasma Hyopneumoniae Vaccine Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific Mycoplasma Hyopneumoniae Vaccine Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific Mycoplasma Hyopneumoniae Vaccine Sales by Region (2020-2025) & (K Units)
 Table 37. Asia Pacific Mycoplasma Hyopneumoniae Vaccine Sales by Region (2026-2031) & (K Units)
 Table 38. Asia Pacific Mycoplasma Hyopneumoniae Vaccine Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific Mycoplasma Hyopneumoniae Vaccine Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Mycoplasma Hyopneumoniae Vaccine Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America Mycoplasma Hyopneumoniae Vaccine Sales by Country (2020-2025) & (K Units)
 Table 42. Latin America Mycoplasma Hyopneumoniae Vaccine Sales by Country (2026-2031) & (K Units)
 Table 43. Latin America Mycoplasma Hyopneumoniae Vaccine Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Mycoplasma Hyopneumoniae Vaccine Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa Mycoplasma Hyopneumoniae Vaccine Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa Mycoplasma Hyopneumoniae Vaccine Sales by Country (2020-2025) & (K Units)
 Table 47. Middle East and Africa Mycoplasma Hyopneumoniae Vaccine Sales by Country (2026-2031) & (K Units)
 Table 48. Middle East and Africa Mycoplasma Hyopneumoniae Vaccine Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa Mycoplasma Hyopneumoniae Vaccine Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global Mycoplasma Hyopneumoniae Vaccine Sales (K Units) by Type (2020-2025)
 Table 51. Global Mycoplasma Hyopneumoniae Vaccine Sales (K Units) by Type (2026-2031)
 Table 52. Global Mycoplasma Hyopneumoniae Vaccine Sales Market Share by Type (2020-2025)
 Table 53. Global Mycoplasma Hyopneumoniae Vaccine Sales Market Share by Type (2026-2031)
 Table 54. Global Mycoplasma Hyopneumoniae Vaccine Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global Mycoplasma Hyopneumoniae Vaccine Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global Mycoplasma Hyopneumoniae Vaccine Revenue Market Share by Type (2020-2025)
 Table 57. Global Mycoplasma Hyopneumoniae Vaccine Revenue Market Share by Type (2026-2031)
 Table 58. Global Mycoplasma Hyopneumoniae Vaccine Price (US$/Unit) by Type (2020-2025)
 Table 59. Global Mycoplasma Hyopneumoniae Vaccine Price (US$/Unit) by Type (2026-2031)
 Table 60. Global Mycoplasma Hyopneumoniae Vaccine Sales (K Units) by Application (2020-2025)
 Table 61. Global Mycoplasma Hyopneumoniae Vaccine Sales (K Units) by Application (2026-2031)
 Table 62. Global Mycoplasma Hyopneumoniae Vaccine Sales Market Share by Application (2020-2025)
 Table 63. Global Mycoplasma Hyopneumoniae Vaccine Sales Market Share by Application (2026-2031)
 Table 64. Global Mycoplasma Hyopneumoniae Vaccine Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global Mycoplasma Hyopneumoniae Vaccine Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global Mycoplasma Hyopneumoniae Vaccine Revenue Market Share by Application (2020-2025)
 Table 67. Global Mycoplasma Hyopneumoniae Vaccine Revenue Market Share by Application (2026-2031)
 Table 68. Global Mycoplasma Hyopneumoniae Vaccine Price (US$/Unit) by Application (2020-2025)
 Table 69. Global Mycoplasma Hyopneumoniae Vaccine Price (US$/Unit) by Application (2026-2031)
 Table 70. Zoetis Company Information
 Table 71. Zoetis Description and Business Overview
 Table 72. Zoetis Mycoplasma Hyopneumoniae Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 73. Zoetis Mycoplasma Hyopneumoniae Vaccine Product
 Table 74. Zoetis Recent Developments/Updates
 Table 75. Merck Company Information
 Table 76. Merck Description and Business Overview
 Table 77. Merck Mycoplasma Hyopneumoniae Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 78. Merck Mycoplasma Hyopneumoniae Vaccine Product
 Table 79. Merck Recent Developments/Updates
 Table 80. Boehringer Ingelheim Company Information
 Table 81. Boehringer Ingelheim Description and Business Overview
 Table 82. Boehringer Ingelheim Mycoplasma Hyopneumoniae Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 83. Boehringer Ingelheim Mycoplasma Hyopneumoniae Vaccine Product
 Table 84. Boehringer Ingelheim Recent Developments/Updates
 Table 85. Ceva Santé Animale Company Information
 Table 86. Ceva Santé Animale Description and Business Overview
 Table 87. Ceva Santé Animale Mycoplasma Hyopneumoniae Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 88. Ceva Santé Animale Mycoplasma Hyopneumoniae Vaccine Product
 Table 89. Ceva Santé Animale Recent Developments/Updates
 Table 90. Elanco Animal Health Company Information
 Table 91. Elanco Animal Health Description and Business Overview
 Table 92. Elanco Animal Health Mycoplasma Hyopneumoniae Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 93. Elanco Animal Health Mycoplasma Hyopneumoniae Vaccine Product
 Table 94. Elanco Animal Health Recent Developments/Updates
 Table 95. Qilu Animal Health Company Information
 Table 96. Qilu Animal Health Description and Business Overview
 Table 97. Qilu Animal Health Mycoplasma Hyopneumoniae Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 98. Qilu Animal Health Mycoplasma Hyopneumoniae Vaccine Product
 Table 99. Qilu Animal Health Recent Developments/Updates
 Table 100. Ruipu Company Information
 Table 101. Ruipu Description and Business Overview
 Table 102. Ruipu Mycoplasma Hyopneumoniae Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 103. Ruipu Mycoplasma Hyopneumoniae Vaccine Product
 Table 104. Ruipu Recent Developments/Updates
 Table 105. Shanghai Hile Bio-Technology Co., Ltd. Company Information
 Table 106. Shanghai Hile Bio-Technology Co., Ltd. Description and Business Overview
 Table 107. Shanghai Hile Bio-Technology Co., Ltd. Mycoplasma Hyopneumoniae Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 108. Shanghai Hile Bio-Technology Co., Ltd. Mycoplasma Hyopneumoniae Vaccine Product
 Table 109. Shanghai Hile Bio-Technology Co., Ltd. Recent Developments/Updates
 Table 110. CAHIC Company Information
 Table 111. CAHIC Description and Business Overview
 Table 112. CAHIC Mycoplasma Hyopneumoniae Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 113. CAHIC Mycoplasma Hyopneumoniae Vaccine Product
 Table 114. CAHIC Recent Developments/Updates
 Table 115. Pulike Company Information
 Table 116. Pulike Description and Business Overview
 Table 117. Pulike Mycoplasma Hyopneumoniae Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 118. Pulike Mycoplasma Hyopneumoniae Vaccine Product
 Table 119. Pulike Recent Developments/Updates
 Table 120. Harbin Pharmaceutical Group Company Information
 Table 121. Harbin Pharmaceutical Group Description and Business Overview
 Table 122. Harbin Pharmaceutical Group Mycoplasma Hyopneumoniae Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 123. Harbin Pharmaceutical Group Mycoplasma Hyopneumoniae Vaccine Product
 Table 124. Harbin Pharmaceutical Group Recent Developments/Updates
 Table 125. Key Raw Materials Lists
 Table 126. Raw Materials Key Suppliers Lists
 Table 127. Mycoplasma Hyopneumoniae Vaccine Distributors List
 Table 128. Mycoplasma Hyopneumoniae Vaccine Customers List
 Table 129. Mycoplasma Hyopneumoniae Vaccine Market Trends
 Table 130. Mycoplasma Hyopneumoniae Vaccine Market Drivers
 Table 131. Mycoplasma Hyopneumoniae Vaccine Market Challenges
 Table 132. Mycoplasma Hyopneumoniae Vaccine Market Restraints
 Table 133. Research Programs/Design for This Report
 Table 134. Key Data Information from Secondary Sources
 Table 135. Key Data Information from Primary Sources
 Table 136. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Mycoplasma Hyopneumoniae Vaccine
 Figure 2. Global Mycoplasma Hyopneumoniae Vaccine Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Mycoplasma Hyopneumoniae Vaccine Market Share by Type: 2024 & 2031
 Figure 4. Live Product Picture
 Figure 5. Inactivated Product Picture
 Figure 6. Global Mycoplasma Hyopneumoniae Vaccine Market Value by Application (2020-2031) & (US$ Million)
 Figure 7. Global Mycoplasma Hyopneumoniae Vaccine Market Share by Application: 2024 & 2031
 Figure 8. Piglets
 Figure 9. Adult Pigs
 Figure 10. Global Mycoplasma Hyopneumoniae Vaccine Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 11. Global Mycoplasma Hyopneumoniae Vaccine Market Size (2020-2031) & (US$ Million)
 Figure 12. Global Mycoplasma Hyopneumoniae Vaccine Sales (2020-2031) & (K Units)
 Figure 13. Global Mycoplasma Hyopneumoniae Vaccine Average Price (US$/Unit) & (2020-2031)
 Figure 14. Mycoplasma Hyopneumoniae Vaccine Report Years Considered
 Figure 15. Mycoplasma Hyopneumoniae Vaccine Sales Share by Manufacturers in 2024
 Figure 16. Global Mycoplasma Hyopneumoniae Vaccine Revenue Share by Manufacturers in 2024
 Figure 17. Global 5 and 10 Largest Mycoplasma Hyopneumoniae Vaccine Players: Market Share by Revenue in Mycoplasma Hyopneumoniae Vaccine in 2024
 Figure 18. Mycoplasma Hyopneumoniae Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 19. Global Mycoplasma Hyopneumoniae Vaccine Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 20. North America Mycoplasma Hyopneumoniae Vaccine Sales Market Share by Country (2020-2031)
 Figure 21. North America Mycoplasma Hyopneumoniae Vaccine Revenue Market Share by Country (2020-2031)
 Figure 22. United States Mycoplasma Hyopneumoniae Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 23. Canada Mycoplasma Hyopneumoniae Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 24. Europe Mycoplasma Hyopneumoniae Vaccine Sales Market Share by Country (2020-2031)
 Figure 25. Europe Mycoplasma Hyopneumoniae Vaccine Revenue Market Share by Country (2020-2031)
 Figure 26. Germany Mycoplasma Hyopneumoniae Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 27. France Mycoplasma Hyopneumoniae Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 28. U.K. Mycoplasma Hyopneumoniae Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 29. Italy Mycoplasma Hyopneumoniae Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 30. Russia Mycoplasma Hyopneumoniae Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 31. Asia Pacific Mycoplasma Hyopneumoniae Vaccine Sales Market Share by Region (2020-2031)
 Figure 32. Asia Pacific Mycoplasma Hyopneumoniae Vaccine Revenue Market Share by Region (2020-2031)
 Figure 33. China Mycoplasma Hyopneumoniae Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 34. Japan Mycoplasma Hyopneumoniae Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 35. South Korea Mycoplasma Hyopneumoniae Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 36. India Mycoplasma Hyopneumoniae Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 37. Australia Mycoplasma Hyopneumoniae Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 38. China Taiwan Mycoplasma Hyopneumoniae Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 39. Indonesia Mycoplasma Hyopneumoniae Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 40. Thailand Mycoplasma Hyopneumoniae Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 41. Malaysia Mycoplasma Hyopneumoniae Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 42. Latin America Mycoplasma Hyopneumoniae Vaccine Sales Market Share by Country (2020-2031)
 Figure 43. Latin America Mycoplasma Hyopneumoniae Vaccine Revenue Market Share by Country (2020-2031)
 Figure 44. Mexico Mycoplasma Hyopneumoniae Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 45. Brazil Mycoplasma Hyopneumoniae Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 46. Argentina Mycoplasma Hyopneumoniae Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 47. Middle East and Africa Mycoplasma Hyopneumoniae Vaccine Sales Market Share by Country (2020-2031)
 Figure 48. Middle East and Africa Mycoplasma Hyopneumoniae Vaccine Revenue Market Share by Country (2020-2031)
 Figure 49. Turkey Mycoplasma Hyopneumoniae Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 50. Saudi Arabia Mycoplasma Hyopneumoniae Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 51. UAE Mycoplasma Hyopneumoniae Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 52. Global Sales Market Share of Mycoplasma Hyopneumoniae Vaccine by Type (2020-2031)
 Figure 53. Global Revenue Market Share of Mycoplasma Hyopneumoniae Vaccine by Type (2020-2031)
 Figure 54. Global Mycoplasma Hyopneumoniae Vaccine Price (US$/Unit) by Type (2020-2031)
 Figure 55. Global Sales Market Share of Mycoplasma Hyopneumoniae Vaccine by Application (2020-2031)
 Figure 56. Global Revenue Market Share of Mycoplasma Hyopneumoniae Vaccine by Application (2020-2031)
 Figure 57. Global Mycoplasma Hyopneumoniae Vaccine Price (US$/Unit) by Application (2020-2031)
 Figure 58. Mycoplasma Hyopneumoniae Vaccine Value Chain
 Figure 59. Channels of Distribution (Direct Vs Distribution)
 Figure 60. Bottom-up and Top-down Approaches for This Report
 Figure 61. Data Triangulation
 Figure 62. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Novocure

SIMILAR REPORTS

Global Swine Mycoplasma Hyopneumoniae Vaccine Market Research Report 2025
Swine Mycoplasma Pneumonia Live Vaccine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Swine Mycoplasma Vaccine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Inactivated Vaccine for Swine Mycoplasma Pneumonia Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Porcine Circovirus Mycoplasma Hyopneumoniae Vaccine Market Research Report 2024
Swine Hyopneumoniae Mycoplasma Inactivated Vaccine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Mycoplasma Galliscepticum Vaccine Market Research Report 2024
Swine Streptococcus Vaccine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Equine Rhinopneumonitis Vaccine Market Research Report 2024
Pneumococcal Vaccine Market Size Manufacturers Supply Chain Sales Channel and Clients 2021 2027
Global Pneumococcal Vaccination Market Research Report 2025
Global Pneumonia Vaccine Market Insights Forecast to 2030
Global Swine Parvovirus Disease Vaccine Market Research Report 2024
Porcine Vaccines Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Porcine Circovirus Diseases Vaccine Market Research Report 2024
Global Polyvalent Streptococcus Pneumococcal Vaccines Market Research Report 2025
Global Poultry and Livestock Vaccines Market Research Report 2025
Global Mycoplasma Pneumoniae Antibodies Market Research Report 2024
Pneumococcal Bacteria Vaccine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Swine Influenza Vaccines Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions